Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIa PK and safety study of aztreonam-avibactam in complicated intra-abdominal infections
2015-002726-39Phase 2Completed
- Sponsor
- Pfizer
- Start
- Dec 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of aztreonam + avibactam in Intra-abdominal infection (IAI), sponsored by Pfizer. Primary endpoints: Plasma concentrations of aztreonam and avibactam and Safety and tolerability of aztreonam-avibactam. Started Dec 2015; status: completed.
02
Drugs
aztreonam + avibactam
03
Conditions
Intra-abdominal infection (IAI)
Beyond the preview
Go deeper on 2015-002726-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-002726-39.